Author/Authors :
Khedmat, Hossein baqiyatallah university of medical sciences - Baqiyatallah Research Center for Gastroenterology and Liver Disease, ايران , Amini, Mohsen baqiyatallah university of medical sciences - Baqiyatallah Research Center for Gastroenterology and Liver Diseases, ايران , Ghamar-Chehreh, Mohammad Ebrahim baqiyatallah university of medical sciences - Baqiyatallah Research Center for Gastroenterology and Liver Disease, ايران , Agah, Shahram Tehran University of Medical Sciences - Colorectal Research Center, ايران
Abstract :
Despite the introduction of strict hygienic precautions preventing infection spread of hepatitis C virus (HCV) in dialysis settings,this infection is still prevalent among dialysis patients due to procedures making the patients vulnerable to infection through blood contamination. Treatment of HCV infection in dialysis patients is also less successful than that in the non-uremic population due to contraindication of using ribavirin,a main drug,in the infected patients. In this review article we aim to investigate the feasibility of the current antiviral therapies in dialysis patients infected with HCV infection.
